Best TWAS P=2.59e-11 · Best GWAS P=7.09e-10 conditioned to 0.678
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | GATAD2A | 0.13 | 0.30 | lasso | 7 | 0.29 | 2.4e-35 | 5.1 | -5.2 | 2.2e-07 | -0.60 | 0.58 | 0.42 | FALSE |
2 | CommonMind | Brain Pre-frontal Cortex | HAPLN4 | 0.07 | 0.10 | lasso | 6 | 0.10 | 5.3e-12 | 5.8 | 5.9 | 3.0e-09 | 0.73 | 0.04 | 0.96 | FALSE |
3 | GTEx | Brain Cerebellar Hemisphere | ATP13A1 | 0.19 | 0.15 | lasso | 2 | 0.07 | 7.3e-03 | 5.2 | 5.2 | 2.1e-07 | 0.66 | 0.07 | 0.43 | FALSE |
4 | GTEx | Brain Cerebellum | SUGP2 | 0.15 | -0.01 | enet | 27 | 0.00 | 2.3e-01 | 5.6 | 6.6 | 4.8e-11 | 0.55 | 0.05 | 0.45 | TRUE |
5 | GTEx | Brain Cerebellum | PBX4 | 0.20 | 0.09 | lasso | 6 | 0.13 | 9.9e-05 | 5.6 | 5.7 | 1.3e-08 | 0.82 | 0.07 | 0.75 | FALSE |
6 | GTEx | Cells Transformed fibroblasts | LPAR2 | 0.04 | 0.05 | lasso | 2 | 0.04 | 5.5e-04 | 6.2 | -6.2 | 4.8e-10 | -0.97 | 0.01 | 0.96 | FALSE |
7 | GTEx | Colon Transverse | YJEFN3 | 0.09 | 0.09 | lasso | 3 | 0.07 | 4.3e-04 | 5.4 | -5.6 | 1.9e-08 | -0.72 | 0.04 | 0.91 | FALSE |
8 | GTEx | Esophagus Mucosa | LPAR2 | 0.08 | 0.03 | lasso | 2 | 0.01 | 1.1e-01 | 5.1 | -5.2 | 2.1e-07 | -0.67 | 0.07 | 0.79 | FALSE |
9 | GTEx | Lung | LPAR2 | 0.07 | 0.09 | lasso | 3 | 0.05 | 9.9e-05 | 6.2 | -6.4 | 2.0e-10 | -0.98 | 0.00 | 1.00 | FALSE |
10 | GTEx | Muscle Skeletal | SUGP1 | 0.11 | 0.06 | lasso | 7 | 0.07 | 9.5e-08 | 5.8 | -5.8 | 6.4e-09 | -0.73 | 0.06 | 0.94 | FALSE |
11 | GTEx | Nerve Tibial | LPAR2 | 0.14 | 0.05 | lasso | 5 | 0.06 | 2.3e-05 | 6.2 | -6.0 | 2.1e-09 | -0.97 | 0.01 | 0.99 | FALSE |
12 | GTEx | Spleen | LPAR2 | 0.27 | 0.06 | lasso | 6 | 0.04 | 2.7e-02 | 5.3 | -6.7 | 2.6e-11 | -0.85 | 0.03 | 0.74 | TRUE |
13 | GTEx | Thyroid | YJEFN3 | 0.05 | 0.02 | lasso | 3 | 0.02 | 1.2e-02 | 6.1 | -5.9 | 3.0e-09 | -0.72 | 0.04 | 0.86 | FALSE |
14 | GTEx | Whole Blood | TMEM161A | 0.06 | 0.00 | enet | 2 | 0.00 | 1.4e-01 | 5.2 | -5.2 | 1.8e-07 | -0.57 | 0.15 | 0.28 | FALSE |
15 | GTEx | Whole Blood | LPAR2 | 0.10 | 0.07 | lasso | 5 | 0.07 | 8.0e-07 | 6.2 | -6.4 | 1.4e-10 | -0.90 | 0.01 | 0.99 | FALSE |
16 | NTR | Blood | LPAR2 | 0.04 | 0.03 | lasso | 3 | 0.03 | 3.6e-11 | 6.2 | -5.4 | 8.6e-08 | -0.90 | 0.00 | 1.00 | FALSE |
17 | ROSMAP | Brain Pre-frontal Cortex | TSSK6 | 0.04 | 0.00 | blup | 346 | 0.01 | 1.1e-02 | 5.2 | 5.2 | 2.0e-07 | 0.67 | 0.06 | 0.85 | FALSE |
18 | YFS | Blood | LPAR2 | 0.14 | 0.15 | lasso | 5 | 0.16 | 3.6e-48 | 6.1 | -6.0 | 2.2e-09 | -0.96 | 0.00 | 1.00 | FALSE |
19 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | YJEFN3 | 0.04 | 0.05 | lasso | 7 | 0.04 | 1.6e-04 | 5.5 | -6.0 | 1.6e-09 | -0.82 | 0.01 | 0.96 | FALSE |
20 | The Cancer Genome Atlas | Breast Invasive Carcinoma | CILP2 | 0.02 | 0.02 | blup | 30 | 0.02 | 1.6e-04 | 5.5 | 5.6 | 2.3e-08 | 0.73 | 0.01 | 0.95 | FALSE |
21 | The Cancer Genome Atlas | Breast Invasive Carcinoma | HAPLN4 | 0.04 | 0.07 | lasso | 4 | 0.06 | 1.3e-12 | 5.3 | 5.6 | 2.1e-08 | 0.72 | 0.01 | 0.99 | FALSE |
22 | The Cancer Genome Atlas | Colon Adenocarcinoma | GATAD2A | 0.04 | 0.03 | blup | 61 | 0.05 | 1.3e-03 | 5.2 | 5.7 | 9.5e-09 | 0.70 | 0.05 | 0.73 | FALSE |
23 | The Cancer Genome Atlas | Colon Adenocarcinoma | HAPLN4 | 0.10 | 0.08 | blup | 38 | 0.11 | 8.5e-07 | 4.5 | 5.3 | 1.3e-07 | 0.66 | 0.04 | 0.96 | FALSE |
24 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | GATAD2A | 0.02 | 0.02 | lasso | 1 | 0.02 | 2.1e-03 | 5.1 | 5.1 | 2.9e-07 | 0.57 | 0.07 | 0.22 | FALSE |
25 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | HAPLN4 | 0.07 | 0.05 | lasso | 7 | 0.07 | 2.9e-08 | 5.9 | 5.9 | 4.2e-09 | 0.70 | 0.00 | 1.00 | FALSE |
26 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | GMIP | 0.03 | 0.02 | lasso | 4 | 0.02 | 3.2e-03 | 6.2 | 5.9 | 3.3e-09 | 0.94 | 0.00 | 0.94 | FALSE |
27 | The Cancer Genome Atlas | Brain Lower Grade Glioma | TSSK6 | 0.02 | 0.02 | blup | 33 | 0.02 | 1.8e-03 | 5.1 | 6.2 | 7.7e-10 | 0.72 | 0.03 | 0.64 | FALSE |
28 | The Cancer Genome Atlas | Prostate Adenocarcinoma | YJEFN3 | 0.04 | 0.05 | lasso | 2 | 0.05 | 4.3e-06 | 5.5 | -5.5 | 3.9e-08 | -0.73 | 0.01 | 0.99 | FALSE |
29 | The Cancer Genome Atlas | Soft Tissue Sarcoma | HAPLN4 | 0.11 | 0.01 | blup | 38 | 0.02 | 2.7e-02 | 5.9 | 6.0 | 1.9e-09 | 0.75 | 0.01 | 0.88 | FALSE |
30 | The Cancer Genome Atlas | Thyroid Carcinoma | HAPLN4 | 0.08 | 0.06 | blup | 37 | 0.09 | 1.8e-09 | 4.8 | 5.7 | 1.2e-08 | 0.63 | 0.02 | 0.98 | FALSE |
31 | The Cancer Genome Atlas | Thyroid Carcinoma | YJEFN3 | 0.08 | 0.06 | blup | 33 | 0.08 | 7.1e-08 | 5.5 | -5.1 | 2.8e-07 | -0.79 | 0.01 | 0.99 | FALSE |